Humana Announces Key Strategic Leadership Appointment and Care Delivery Realignment
05 December 2018 - 6:00AM
Business Wire
Names Vishal Agrawal, M.D., Chief Strategy
and Corporate Development Officer
Aligns Care Delivery Organization under
Chief Financial Officer Brian Kane
Humana Inc. (NYSE: HUM), one of the nation’s leading health and
well-being companies, has named Vishal Agrawal, M.D., to the
position of Chief Strategy and Corporate Development Officer.
Humana also announced that it is realigning its Care Delivery
Organization under the leadership of Chief Financial Officer Brian
Kane.
In the role of Chief Strategy and Corporate Development Officer,
Agrawal will report directly to Humana President and CEO Bruce
Broussard, and will serve as a member of Humana’s Management Team.
Agrawal will be responsible for advancing the company’s strategic
insights and planning process, establishing direction for merger,
acquisition and joint venture activities, while maximizing
capabilities to create competitive advantage. He will assume the
role effective December 10, 2018.
Agrawal brings more than 20 years of experience in planning and
implementing strategies to drive growth and performance improvement
across publicly traded and privately held health care
organizations. He comes to Humana from The Carlyle Group, a
Washington, D.C.-based financial services and investment firm,
where he served as Senior Advisor. Previously, Agrawal oversaw
strategy for Ciox Health, a health care information management
company, as President and Chief Growth Officer. Agrawal has also
served as President of Harris Healthcare Solutions and Partner at
McKinsey and Company.
“As a physician and a highly strategic health care business
leader, Vishal’s expertise spans multiple domains,” said Broussard.
“His unique perspective will help Humana continue to advance its
integrated care delivery market strategy, which revolves around the
health plan member, with a particular focus on seniors living with
chronic conditions.”
Agrawal is a graduate of the Yale University School of Medicine.
He also holds a master’s degree in molecular biophysics and a
bachelor’s degree in molecular biophysics and biochemistry, both
also from Yale.
As Chief Strategy and Corporate Development Officer, Agrawal
succeeds Christopher Hunter, who recently assumed leadership
responsibility for the company’s
Group, Specialty and Military lines of business.
Hunter, who joined the company in 2014, has played an instrumental
role in advancing the company’s strategy, particularly as the
company emerged as a stand-alone entity after the termination of
the Aetna transaction. Chris succeeds Beth Bierbower in this role,
who as previously announced, is leading the company’s efforts to
develop a new senior health care experience in the company’s
recently created Humana Studio H in Boston. Both Hunter and
Bierbower are members of the Management Team reporting to
Broussard.
In addition, Humana’s Care Delivery Organization will now become
part of the company’s Finance organization, under the leadership of
Chief Financial Officer Brian Kane. An important part of Humana’s
integrated care delivery strategy involves expanding clinical
capabilities with a commitment to providing care delivery solutions
to serve the members of many different payors.
“Our desire to grow payor-agnostic care delivery through
acquisitions and de novo centers will be further realized by
realigning the entity to the Finance organization,” said Broussard.
“There, the Care Delivery Organization can leverage the operational
and financial expertise of Brian Kane and his leadership team to
advance its primary care capabilities.”
Reporting to Kane will be Renee Buckingham, president of
Humana’s Care Delivery Organization. In a short period of time,
Renee and her team have helped facilitate the reorganization of
existing Florida and Texas care delivery assets into Conviva,
consummated the acquisition and subsequent integration of central
Florida’s Family Physicians Group, and driven the growth of
Partners in Primary Care (PIPC) by entering new markets with PIPC
centers, broadening the relationship with several of the company’s
joint venture partners and establishing a strategic
partnership with Walgreens to
co-locate senior-focused PIPC centers
in certain Kansas City-area stores.
About Humana
Humana Inc. is committed to helping our millions of medical and
specialty members achieve their best health. Our successful history
in care delivery and health plan administration is helping us
create a new kind of integrated care with the power to improve
health and well-being and lower costs. Our efforts are leading to a
better quality of life for people with Medicare, families,
individuals, military service personnel, and communities at
large.
To accomplish that, we support physicians and other health care
professionals as they work to deliver the right care in the right
place for their patients, our members. Our range of clinical
capabilities, resources and tools – such as in-home care,
behavioral health, pharmacy services, data analytics and wellness
solutions – combine to produce a simplified experience that makes
health care easier to navigate and more effective.
More information regarding Humana is available to investors via
the Investor Relations page of the company’s web site at
www.humana.com, including copies of:
- Annual reports to stockholders
- Securities and Exchange Commission
filings
- Most recent investor conference
presentations
- Quarterly earnings news releases and
conference calls
- Calendar of events
- Corporate Governance information
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181204005752/en/
Tom NolandHumana Corporate
Communications502-580-3674tnoland@humana.com
Amy SmithHumana Investor Relations(502)
580-2811amysmith@humana.com
Humana (NYSE:HUM)
Historical Stock Chart
From Apr 2024 to May 2024
Humana (NYSE:HUM)
Historical Stock Chart
From May 2023 to May 2024